Response to letter entitled: Re: 'Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial'. (October 2022) - Shi, Changying; Li, Yong; Geng, Li; Shen, Weifeng; Sui, Chengjun; Dai, Binghua; Lu, Jiongjiong; Pan, Mianshun; Yang, Jiamei